modelCaffeine_Guo2020_reference
Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_1C.
Information
| name: | caffeine |
| ATC code: | N06BC01 |
| model: | one compartment, IV dosing (PK_1C) |
| source: | Guo A et al. 2020 |
| population: | Chinese premature infants with apnea |
| measured compound: | caffeine |
| review: | curated candidate |
| record page: | pharmacolibrary-docs |
Parameters as reported in the paper
| parameter | value | unit | meaning |
|---|---|---|---|
| clearance | 0.268 | L/h | CL |
| volume of distribution (V) | 109 | L | V |
About caffeine
Caffeine is a stimulant used to treat breathing problems such as apnea in newborns, and is also used in dermatological and diagnostic preparations. It is widely used and authorised in the European Union, mainly for apnea of prematurity.
Summary written by glm-5.3-flash from Wikidata Q60235 and the WHO ATC classification and the EMA medicines list; not checked by a person.
Identity, molar mass and metabolites: Caffeine.
References
Guo A et al. (2020). Population pharmacokinetic study of caffeine citrate in Chinese premature infants with apnea. Journal of clinical pharmacy and therapeutics 45(6):1414–1421. DOI:10.1111/jcpt.13240 PUBMED:32737938
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| Real | Cl_ref | 7.444444444444444e-08 | Cl [m3/s] |
| Real | Vd_ref | 0.109 | Vd [m3] |
| Modelica.Units.SI.Mass | weight (from PK_1C) | 75 | patient weight (kg) |
| Modelica.Units.SI.SpecificVolume | VdPerKg (from PK_1C) | 0.0009 | Volume of distribution per kg (default 0.9 L/kg) |
| Modelica.Units.SI.MassFraction | F (from PK_1C) | 1 | bioavailability (0-1) |
| Pharmacolibrary.Types.Clearance | Cl (from PK_1C) | 2.7777777777777776e-7 | clearance |
| Modelica.Units.SI.Time | adminTime (from PK_1C) | 60 | first administration time (s) |
| Modelica.Units.SI.Time | adminDuration (from PK_1C) | 600 | administration duration (s) |
| Modelica.Units.SI.Time | adminPeriod (from PK_1C) | 8*60*60 | period of administration (default 8 hours)(s) |
| Pharmacolibrary.Types.Mass | adminMass (from PK_1C) | 1e-4 | administration mass (mg) |
| Integer | adminCount (from PK_1C) | 8 | number of dose administered (1) |
| Pharmacolibrary.Types.Volume | Vd (from PK_1C) | VdPerKg*weight | Volume of distribution (m3) |
| Info › Therapeutic range (metadata, not used in equations) | |||
| Pharmacolibrary.Types.MassConcentration | Cmin (from PK_1C) | 0.004 | minimal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Cmax (from PK_1C) | 0.008 | maximal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Ctox_peak (from PK_1C) | 0.012 | toxicity peak level |
| Pharmacolibrary.Types.MassConcentration | Ctox_trough (from PK_1C) | 0.006 | toxicity trough level |
| Info › Substance metadata | |||
| Modelica.Units.SI.MolarMass | MM (from PK_1C) | 0 | molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0) |
| Info › Substance metadata (not used in equations) | |||
| Pharmacolibrary.Types.Dose | LD50 (from PK_1C) | 0 | median lethal dose [mg/kg]; 0 = unknown |
Connectors
| Type | Name | Default | Description |
|---|---|---|---|
| Types.ConcentrationOutput | C_central (from PK_1C) | ||
| Interfaces.ConcentrationPort_b | centralCPort (from PK_1C) |
Components
| Type | Name | Default | Description |
|---|---|---|---|
| Pharmacokinetic.NoPerfusedTissueCompartment | central (from PK_1C) | ||
| Pharmacokinetic.ClearanceDrivenElimination | elim (from PK_1C) | ||
| Sources.PeriodicDose | periodicDose (from PK_1C) | ||
| Modelica.Units.SI.Time | t1_2 (from PK_1C) | central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models) |
Revisions
- 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Guo_2020: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: curated candidate